Cargando…
First person – Melissa Hinman
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Melissa Hinman is first author on ‘ Zebrafish mbnl mutants model physical and molecular phe...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246270/ http://dx.doi.org/10.1242/dmm.049118 |
_version_ | 1783716280500486144 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Melissa Hinman is first author on ‘ Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy’, published in DMM. Melissa is a postdoctoral fellow in the lab of Dr Karen Guillemin at the University of Oregon, Eugene, OR, USA, using zebrafish models to better understand the mechanisms underlying the phenotypes of the genetic disorder myotonic dystrophy and to develop potential therapeutics. |
format | Online Article Text |
id | pubmed-8246270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-82462702021-07-06 First person – Melissa Hinman Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Melissa Hinman is first author on ‘ Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy’, published in DMM. Melissa is a postdoctoral fellow in the lab of Dr Karen Guillemin at the University of Oregon, Eugene, OR, USA, using zebrafish models to better understand the mechanisms underlying the phenotypes of the genetic disorder myotonic dystrophy and to develop potential therapeutics. The Company of Biologists Ltd 2021-06-14 /pmc/articles/PMC8246270/ http://dx.doi.org/10.1242/dmm.049118 Text en © 2021. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Melissa Hinman |
title | First person – Melissa Hinman |
title_full | First person – Melissa Hinman |
title_fullStr | First person – Melissa Hinman |
title_full_unstemmed | First person – Melissa Hinman |
title_short | First person – Melissa Hinman |
title_sort | first person – melissa hinman |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246270/ http://dx.doi.org/10.1242/dmm.049118 |